Angina Clinical Trial
Official title:
A Trial Comparing the Effectiveness and Tolerability of Medications in Older Adults With Stable Angina and Multiple Chronic Conditions: LIVEBETTER
To establish the effectiveness and tolerability of standard of care anti-anginal treatment (beta-blocker and calcium channel blocker medications) in older adults with symptomatic Stable Ischemic Heart Disease (SIHD) and multiple chronic conditions (MCC).
Single-blind, randomized (1:1) pragmatic trial comparing Beta-Blocker therapy versus Calcium Channel Blocker therapy in older adults with symptomatic SIHD and MCC with plans to initiate medical treatment with anti-anginal therapy. Study Aims Aim 1: To compare the effectiveness of anti-anginal medications to improve the symptoms, function, and quality of life among older adults with multiple chronic conditions presenting with stable angina. Aim 2: To compare the tolerability and safety of commonly used anti-anginal medications in older adults with multiple chronic conditions presenting with stable angina. Aim 3 (Exploratory): To compare the long-term effectiveness and safety of specific anti-anginal medicine treatment approaches in older adults with multiple chronic conditions presenting with stable angina. LIVEBETTER consists of 4 study visits during the 12-month follow-up period. Visits are comprised of an interview, six-minute walk, and medical record review. Medication dose and administration will be addressed as part of routine clinical care. The importance of the knowledge gained includes the following: 1. LIVEBETTER will produce randomized contemporary data on the safety and efficacy of BBs vs CCBs with the goal of filling that gap of evidence in the guidelines and informing clinical practice. 2. LIVEBETTER will generate data on the quality of life, symptomatic, and functional outcomes most pertinent to older adults with multiple chronic conditions and stable angina. 3. LIVEBETTER will provide the first quantitative data on caregiver burden in older adults with stable angina. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04097912 -
Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
|
||
| Withdrawn |
NCT03134105 -
A Wearable EducAtional Intervention to REduce Angina
|
N/A | |
| Completed |
NCT02832115 -
Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention
|
Phase 4 | |
| Completed |
NCT02265796 -
Ranolazine Among Unrevascularized Chronic Stable Angina Patients
|
Phase 2 | |
| Terminated |
NCT00221182 -
Stem Cell Study for Patients With Heart Disease
|
Phase 1/Phase 2 | |
| Completed |
NCT01721096 -
XIENCE PRIME Japan Post-Marketing Surveillance (PMS)
|
||
| Recruiting |
NCT01214499 -
Prospective, Controlled and Randomized Clinical Trial on Cardiac Cell Regeneration With Laser and Autologous Bone Marrow Stem Cells, in Patients With Coronary Disease and Refractory Angina
|
Phase 2 | |
| Terminated |
NCT01285297 -
Safety Study of Transmyocardial Revascularization (TMR) With Bone Marrow Aspirate (BMAC) for Angina Reduction
|
N/A | |
| Withdrawn |
NCT00774891 -
Comparison Of Left Ventricular Volume And Wall Stress With Dobutamine And Exercise Echocardiography
|
N/A | |
| Completed |
NCT02707783 -
Feasibility and Outcomes of Complete Coronary Revascularization Using BVS in All-comer Patients With Angina
|
||
| Completed |
NCT02065102 -
Optical Coherence Tomography to Improve Clinical Outcomes During Coronary Angioplasty
|
N/A | |
| Completed |
NCT00946725 -
To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg
|
Phase 1 | |
| Recruiting |
NCT02439541 -
Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy
|
Phase 1/Phase 2 | |
| Completed |
NCT02341664 -
Patient and Provider Assessment of Lipid Management Registry
|
||
| Withdrawn |
NCT00657514 -
Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease
|
Phase 4 | |
| Recruiting |
NCT01361659 -
Shockwave Treatment for Advanced Angina in Maastricht
|
N/A | |
| Withdrawn |
NCT02507050 -
Ivabradine and Post-revascularisation Microcirculatory Dysfunction
|
Phase 4 | |
| Active, not recruiting |
NCT02468960 -
Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds (OPreNBiS)
|
N/A | |
| Completed |
NCT01086228 -
XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan
|
N/A | |
| Completed |
NCT00824005 -
Effectiveness of Stem Cell Treatment for Adults With Ischemic Cardiomyopathy (The FOCUS Study)
|
Phase 2 |